Rita Nanda Free People Check 

( I'm Rita Nanda)

Loading...

Images of Rita Nanda

(1 - 1 from 1 )

News

(1 - 4 from 20
)

History of Changes for Study: NCT ClinicalTrials.govclinicaltrials.gov › history › NCT

clinicaltrials.gov
Contact:Principal Investigator: Rita Nanda, MD. United States, Indiana. Indiana University Health Melvin and Bren Simon Cancer Center [Recruiting]

How Is Triple Negative Breast Cancer Different from Other Diagnoses?www.self.com › Health › breast cancer

www.self.com
May 31, · Doctors used to treat all cases of triple negative breast cancer as just one group, but that's changing, Rita Nanda, M.D., ...

Pembrolizumab plus neoadjuvant chemotherapy linked to higher ...www.healio.com › hematology-oncology › breast-cancer › news › online

www.healio.com
Feb 13, · Rita Nanda. The addition of pembrolizumab to standard neoadjuvant chemotherapy significantly increased estimated pathologic complete ...

ASCO 2017: Addition of Pembrolizumab to JNCCN 360jnccn360.org › breast › news › asco addition-of-pe...

jnccn360.org
... improved pathologic complete response rates in patients with HER2-negative breast cancer, based on the results of the I-SPY 2 trial presented by Rita Nanda, ...
Save as document
+1